Skip to main content
. 2017 Sep 16;8(46):81662–81678. doi: 10.18632/oncotarget.20953

Table 7. Clinical trials with dual PI3K-mTOR inhibitors in head and neck cancer patients.

Compound Combination Phase State NCT number
PF-05212384 PD-0332991 1 Recruiting NCT03065062
Paclitaxel, Carboplatin 1 Recruiting NCT02069158
SF1126 / 2 Recruiting NCT02644122
BEZ235 / 1 Completed NCT00620594

NCT: Number clinicaltrials.gov identifier.